Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, ...

Researchers have discovered a promising new approach to lung cancer treatment. A small molecule called AVJ16 selectively blocks the cancer-driving protein IGF2BP1, halting tumor growth in preclinical ...

Genmab acquires Merus for $8B, boosting cancer drug pipeline with petosemtamab. Check out what this deal means for GMAB and ...

In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, ...

In the midst of another record-breaking year, Klick Health today announced a fresh wave of new senior talent, welcoming 21 ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...

The FDA in September issued two rejections for spinal muscular atrophy therapies—both linked to manufacturing problems—and ...

Investing.com -- Danish biotechnology company Genmab (CSE:GMAB) on Monday said it will acquire Merus N.V., a Dutch biotech, in an $8 billion all-cash transaction, paying $97 per share. Shares of the ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

This article highlights studies that may help inform cancer prevention efforts as well as the treatment of various cancers.